Advertisement

Topics

Latest Biotechnology, Pharmaceutical and Healthcare News - Page: 2 from PR Newswire

05:10 EDT 25th September 2018 | BioPortfolio

Here are the most relevant search results for "PR Newswire" found in our extensive news archives from over 250 global news sources.

More Information about PR Newswire on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about PR Newswire for you to read. Along with our medical data and news we also list PR Newswire Clinical Trials, which are updated daily. BioPortfolio also has a large database of PR Newswire Companies for you to search.

Showing News Articles 26–50 of 291 from PR Newswire

Monday 17th September 2018

Eternity Healthcare Inc. Expects to Complete Stem Cell Facility and Commence Operations by the End of Year and Declare a 2.5 for 1 Stock Dividend

NEW YORK, Sept. 17, 2018 /PRNewswire/ -- Eternity Healthcare Inc. ("Eternity" or the "Company") (OTC: ETAH) today announced that it expects to complete the construction and outfitting of its stem cell facility in Guizhou, Tongren, China, by the end of calendar year 2018. The delay from the initially anticipated completion date of May 2018, was due to changes in the policies gra...

Amorepacific Singapore Empowers Female Cancer Patients with 'makeup your Life' Campaign

SINGAPORE, Sept. 17, 2018 /PRNewswire/ -- In a partnership with the National Cancer Centre Singapore (NCCS), Amorepacific held a beauty workshop, makeup your Life, to educate female cancer patients on how to care for skin that is affected by cancer treatments. In its second year running, the event was held on 15 September 2018 and saw a total of 44 participants come together...

Ping An Good Doctor Participates in the World Artificial Intelligence Conference 2018 to Demonstrate "AI + Health" Innovation

HONG KONG and SHANGHAI, Sept. 17, 2018 /PRNewswire/ -- China's leading one-stop healthcare ecosystem platform, Ping An Good Doctor (the "Company", stock code: 1833.HK), today showed its AI medical devices and technology at the World Artificial Intelligence Conference (WAIC) 2018, including "One-minute Clinics", AI-assisted medical system and Smart Earphone, drawing attenti...

BookDoc collaborates with Chow Tai Fook: Get more rewards by staying active together with Chow Tai Fook

HONG KONG, Sept. 17, 2018 /PRNewswire/ -- Chow Tai Fook is collaborating with BookDoc, the largest integrated healthcare app in Southeast Asia by healthcare network in giving more rewards to BookDoc users for maintaining an active healthy lifestyle. Users can now enjoy discounts and redeem freebies when they purchase jewelleries from Chow Tai Fook by just staying active. For Hong Kong, user c...

Infinitus (China) Named Best Employer-China for the Sixth Time

- Encourages employee innovation and optimizes organizational efficiency. SHANGHAI, Sept. 17, 2018 /PRNewswire/ -- On September 14, 2018, Infinitus (China) Company Ltd. was recognized by Aon Hewitt, a provider of human capital and management consulting services, as a Aon Best Employer in the China 2018 Programme at the awards ceremony held in Shanghai. This i...

Friday 14th September 2018

Frost & Sullivan predicts the smart home as a billion dollar opportunity

SINGAPORE, Sept. 14, 2018 /PRNewswire/ -- The home will emerge as an increasingly valuable site for enhancing the healthcare experience as part of the progression of digital, remote, connected and virtual care. Health systems are evolving beyond care delivery of the diseased to encompass numerous health and wellness touchpoints, transforming it from disease management to health management. T...

Materialise Receives MFDS License For Medical Use of 3D Software in South Korea

MFDS licenses Mimics Medical and ProPlan CMF software to plan surgeries in 3D. LEUVEN, Belgium, Sept. 14, 2018 /PRNewswire/ -- The South Korean Ministry of Food and Drug Safety (MFDS) has licensed the medical use of 3D planning software Mimics Medical and ProPlan CMF. Mimics Research by Materialise (Nasdaq: MTLS) was already available in South Korea for R&D purposes, but with the license for ...

Thursday 13th September 2018

Schizophrenia Breakthrough Discovered at Neuroscience Research Australia (NeuRA)

SYDNEY, Sept. 14, 2018 /PRNewswire/ -- Professor Cynthia Shannon Weickert at Neuroscience Research Australia (NeuRA) has identified immune cells in greater amounts in the brains of some people with schizophrenia. The study published today in Molecular Psychiatry has the potential to transform global schizophrenia research and open new avenues for developing targeted immune cell therapies. Th...

Infinitus Awarded China Charity Award by China's Ministry of Civil Affairs

BEIJING, Sept. 13, 2018 /PRNewswire/ -- Infinitus (China) Company Ltd. was honoured with a China Charity Award from the Ministry of Civil Affairs for its long-term commitment to corporate social responsibility (CSR) and innovation at the 10th China Charity Awards ceremony held in the Great Hall of the People on September 13. The ceremony was chaired by Mr. Huang Shuxian, Minister of...

Haier Biomedical saves lives by moving the blood bank right beside the patient

The laboratory equipment manufacturer's Rendanheyi management model empowers the transformation of the biotechnology ecosystem QINGDAO, China, Sept. 13, 2018 /PRNewswire/ -- Transfusion medicine has been around and under constant improvement for more than 300 years and and nowadays its delivery system of clinical blood has witnessed a landmark change. In orde...

Wednesday 12th September 2018

ExoCoBio Inc. raises $26.7M in Series B Funding

The 4th largest funded exosome startup in the world To help advance its exosome pharmaceutical R&D and cosmeceutical business SEOUL, South Korea, Sept. 12, 2018 /PRNewswire/ -- ExoCoBio Inc. announced that it recently raised about $27 million in its series B funding. Top tier Korean investors participated in this round, including Seven Tree Equity Partners, CSQUARED Global Asset Manag...

Britain still rules the Commonwealth in workplace safety standards

MELBOURNE, Australia, Sept. 12, 2018 /PRNewswire/ -- The United Kingdom sets the benchmark among first world Commonwealth countries when it comes to workplace safety, with the chances of an Australian being fatally injured in the workplace three times higher than a counterpart in Britain. This was the finding of research conducted by Australian Accident Helpline, a national compensation firm from...

Recent Revisions in Chinese Regulations Open New Doors for Contract Research Organizations: Accutest

NAVI MUMBAI, India, Sept. 12, 2018 /PRNewswire/ -- A recent circular issued by the Chinese State Drug Administration (SDA), has opened up a large market for Contract Research Organizations (CROs) across the world. The circular (referred to as No. 52 of 2018) allows Chinese pharmaceutical companies to use clinical trial data from studies conducted outside China for their drug submissions to the S...

Tuesday 11th September 2018

OP Financial Partners with DaChan Food and Biotech Unicorn iCarbonX to Deploy Precision Nutrition Industry

HONG KONG, Sept. 11, 2018 /PRNewswire/ -- The leading cross-border and cross-sector investment company, OP Financial Limited ("OP Financial" or "the Company",stock code: 1140.HK) today announced that OP iCarbonX Investment Limited, the JV established by OP Financial and the biotech unicorn iCarbonX Group Limited (iCarbonX), entered into a series of cooperation agreements with...

The 9th China (Taizhou) International Medical Expo is coming soon

NANJING, China, Sept. 11, 2018 /PRNewswire/ -- The 9th China (Taizhou) International Medicine Expo, with the theme of "Base on Health China, Construct Famous Medical City", will be held in Taizhou, China from September 16 to 18. It has been confirmed that three Nobel Prize winners will attend the opening ceremony of the Expo. Taizhou is a famous historical and cultural city in China and...

Griffith Institute to Collaborate with Australian Health Manufacturer ATP Science

BRISBANE, Australia, Sept. 11, 2018 /PRNewswire/ -- ATP Science Pty Ltd and Research Fellow Dr Miaomiao Liu from the Griffith Institute for Drug Discovery have been awarded the Griffith Sciences Industry Collaborative Grant aimed at developing collaborations with industry partners/end-users. Both ATP Science and Griffith University (GU) will work together to develop a novel plant extraction proc...

First Patient Dosed in a Phase III Trial of Anti-PD-1 Antibody as First-line Treatment for Patients with Non-Squamous Non-Small Cell Lung Cancer

SUZHOU, China, Sept. 11, 2018 /PRNewswire/ -- Innovent Biologics (Innovent), a world-class China-based biopharmaceutical company that develops and commercializes high quality drugs, announced today that the first patient has been dosed in a phase III clinical trial (ORIENT-11) studying sintilimab, a fully human anti-PD-1 monoclonal antibody (IBI308), as first-line treatment for patients with non-s...

Monday 10th September 2018

Sands China Launches Green Mondays as Part of New myFITNESS Initiative

Encourages team member health and wellness MACAU, Sept. 10, 2018 /PRNewswire/ -- Sands China Ltd. is launching myFITNESS, a new initiative aimed at encouraging good habits for team members' health, physical fitness and well-being.

XW Labs Appoints Clinical Development Veteran Dr. Daniel Canafax as Chief Medical Officer

WUHAN, China, Sept. 10, 2018 /PRNewswire/ -- XW Laboratories Inc. (XW Labs), a clinical-stage biopharmaceutical company focused on developing innovative small molecule therapeutics for the treatment of neurological disorders, today announced the appointment of Daniel M. Canafax, PharmD as Chief Medical Officer. Dr. Canafax will lead the global clinical development of XW10172, XW Labs' novel therap...

Korean Ginseng's quality certified by The Korea Ginseng Association through comparative research

SEOUL, South Korea, Sept. 10, 2018 /PRNewswire/ -- The Korea Ginseng Association (http://www.korean-ginseng.org) has provided documented data to prove the superiority of Korean Ginseng and organized a ginseng festival which will take place from October 5 to 28 in key regions across South Korea. A Korean Fresh Ginseng Korean Ginseng was proved in a research in 2002 done by the

Novartis, Mundipharma ink partnership to enhance access in Southeast Asia to two established pain medicine brands

Novartis and Mundipharma, have signed an agreement for the marketing, sales and distribution of well-known pain medicine brands Voltaren® (diclofenac sodium) and Cataflam® (diclofenac potassium) in Malaysia, Thailand, and the Philippines. Novartis will retain a

Innovent's Anti-CD47 Antibody IBI188 Receives IND Approval in China

SUZHOU, China, Sept. 10, 2018 /PRNewswire/ -- Innovent Biologics (Innovent), a world-class China-based biopharmaceutical company that develops and commercializes high quality drugs, today announced that its IND application for IBI188, a fully human anti-CD47 monoclonal antibody (mAb) drug candidate, has been approved by the National Medical Products Administration (NMPA, formerly known as CFD...

Virkon S effective for African Swine Fever biosecurity

LANXESS can offer Asian swine producers a proven disinfectant for preventative farm biosecurity and control measures HO CHI MINH CITY, Vietnam and KUALA LUMPUR, Malaysia, Sept. 10, 2018 /PRNewswire/ -- With China reporting its first outbreak of African Swine Fever (ASF) on August 3rd, and with the heightened threat of this highly contagious disease spreading to Japan and the Korean Peninsula, spe...

Friday 7th September 2018

The "One Belt, One Road" China-Kazakhstan Intelligence Media Forum takes place in Astana

Infinitus (China), the sole sponsor of the event, brings new health solutions to Kazakhstan ASTANA, Kazakhstan, Sept. 8, 2018 /PRNewswire/ --The "One Belt, One Road" China-Kazakhstan Intelligence Media Forum is being held in Astana, the capital of Kazakhstan, on September 7, 2018, bringing together representatives from the Chinese and Kazakhstan governments, as well as policy institutes, media ou...

Luye Pharma's Goserelin Acetate Extended-release Microspheres Start Phase III Clinical Trials in China, Paralleling Smooth Progress with U.S. Regulators

SHANGHAI, Sept. 7, 2018 /PRNewswire/ -- On September 4, Luye Pharma announced that its independently developed drug, Goserelin Acetate Extended-release Microspheres for Injection (LY01005), has entered phase III clinical trials for prostate cancer in China. Meanwhile, LY01005 is currently under phase I clinical trials in the U.S. via part 505(b) (2) of the United States Federal Food, Drug and Cosm...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks